OBJECTIVE: Corticosteroids have been proposed to be effective in modulating the inflammatory response and pulmonary tissue remodeling in acute lung injury (ALI). We hypothesized that steroid treatment might act differently in models of pulmonary (p) or extrapulmonary (exp) ALI with similar mechanical compromise. DESIGN: Prospective, randomized, controlled experimental study. SETTING: University research laboratory. SUBJECTS: One hundred twenty-eight BALB/c mice (20-25 g). INTERVENTIONS: Mice were divided into six groups. In control animals sterile saline solution was intratracheally (0.05 mL, Cp) or intraperitoneally (0.5 mL, Cexp) injected, whereas ALI animals received Escherichia coli lipopolysaccharide intratracheally (10 microg, ALIp) or intraperitoneally (125 microg, ALIexp). Six hours after lipopolysaccharide administration, ALIp and ALIexp animals were further randomized into subgroups receiving saline (0.1 mL intravenously) or methylprednisolone (2 mg/kg intravenously, Mp and Mexp, respectively). MEASUREMENTS AND MAIN RESULTS: At 24 hrs, lung static elastance, resistive and viscoelastic pressures, lung morphometry, and collagen fiber content were similar in both ALI groups. KC, interleukin-6, and transforming growth factor (TGF)-beta levels in bronchoalveolar lavage fluid, as well as tumor necrosis factor (TNF)-alpha, migration inhibitory factor (MIF), interferon (IFN)-gamma, TGF-beta1 and TGF-beta2 messenger RNA expression in lung tissue were higher in ALIp than in ALIexp animals. Methylprednisolone attenuated mechanical and morphometric changes, cytokine levels, and TNF-alpha, MIF, IFNgamma, and TGF-beta2 messenger RNA expression only in ALIp animals, but prevented any changes in collagen fiber content in both ALI groups. CONCLUSIONS: Methylprednisolone is effective to inhibit fibrogenesis independent of the etiology of ALI, but its ability to attenuate inflammatory responses and lung mechanical changes varies according to the cause of ALI.
OBJECTIVE: Corticosteroids have been proposed to be effective in modulating the inflammatory response and pulmonary tissue remodeling in acute lung injury (ALI). We hypothesized that steroid treatment might act differently in models of pulmonary (p) or extrapulmonary (exp) ALI with similar mechanical compromise. DESIGN: Prospective, randomized, controlled experimental study. SETTING: University research laboratory. SUBJECTS: One hundred twenty-eight BALB/c mice (20-25 g). INTERVENTIONS:Mice were divided into six groups. In control animals sterile saline solution was intratracheally (0.05 mL, Cp) or intraperitoneally (0.5 mL, Cexp) injected, whereas ALI animals received Escherichia colilipopolysaccharide intratracheally (10 microg, ALIp) or intraperitoneally (125 microg, ALIexp). Six hours after lipopolysaccharide administration, ALIp and ALIexp animals were further randomized into subgroups receiving saline (0.1 mL intravenously) or methylprednisolone (2 mg/kg intravenously, Mp and Mexp, respectively). MEASUREMENTS AND MAIN RESULTS: At 24 hrs, lung static elastance, resistive and viscoelastic pressures, lung morphometry, and collagen fiber content were similar in both ALI groups. KC, interleukin-6, and transforming growth factor (TGF)-beta levels in bronchoalveolar lavage fluid, as well as tumor necrosis factor (TNF)-alpha, migration inhibitory factor (MIF), interferon (IFN)-gamma, TGF-beta1 and TGF-beta2 messenger RNA expression in lung tissue were higher in ALIp than in ALIexp animals. Methylprednisolone attenuated mechanical and morphometric changes, cytokine levels, and TNF-alpha, MIF, IFNgamma, and TGF-beta2 messenger RNA expression only in ALIp animals, but prevented any changes in collagen fiber content in both ALI groups. CONCLUSIONS:Methylprednisolone is effective to inhibit fibrogenesis independent of the etiology of ALI, but its ability to attenuate inflammatory responses and lung mechanical changes varies according to the cause of ALI.
Authors: Felipe Saddy; Gisele P Oliveira; Cristiane S N B Garcia; Liliane M Nardelli; Andreia F Rzezinski; Debora S Ornellas; Marcelo M Morales; Vera L Capelozzi; Paolo Pelosi; Patricia R M Rocco Journal: Intensive Care Med Date: 2010-03-24 Impact factor: 17.440
Authors: Andrew W Kirkpatrick; Paolo Pelosi; Jan J De Waele; Manu Lng Malbrain; Chad G Ball; Maureen O Meade; Henry T Stelfox; Kevin B Laupland Journal: Crit Care Date: 2010-08-27 Impact factor: 9.097
Authors: Pedro L Silva; Fernanda F Cruz; Livia C Fujisaki; Gisele P Oliveira; Cynthia S Samary; Debora S Ornellas; Tatiana Maron-Gutierrez; Nazareth N Rocha; Regina Goldenberg; Cristiane S N B Garcia; Marcelo M Morales; Vera L Capelozzi; Marcelo Gama de Abreu; Paolo Pelosi; Patricia R M Rocco Journal: Crit Care Date: 2010-06-14 Impact factor: 9.097
Authors: Michael R Wilson; Kieran P O'Dea; Anthony D Dorr; Hirotoshi Yamamoto; Michael E Goddard; Masao Takata Journal: PLoS One Date: 2010-07-13 Impact factor: 3.240
Authors: Paula Tejera; Nuala J Meyer; Feng Chen; Rui Feng; Yang Zhao; D Shane O'Mahony; Lin Li; Chau-Chyun Sheu; Rihong Zhai; Zhaoxi Wang; Li Su; Ed Bajwa; Amy M Ahasic; Peter F Clardy; Michelle N Gong; Angela J Frank; Paul N Lanken; B Taylor Thompson; Jason D Christie; Mark M Wurfel; Grant E O'Keefe; David C Christiani Journal: J Med Genet Date: 2012-10-09 Impact factor: 6.318
Authors: Jan Willem Kuiper; Frans B Plötz; Ab Johan Groeneveld; Jack J Haitsma; Serge Jothy; Rosanna Vaschetto; Haibo Zhang; Arthur S Slutsky Journal: BMC Anesthesiol Date: 2011-12-28 Impact factor: 2.217